Some of Japan’s most forward-thinking minds gathered to scrutinise Japan’s biobank conundrum at Shonan iPark. In […]
Navigating Japan’s life sciences sector successfully hinges on more than just excellent science or a meticulously […]
It started with a headline I read on the train to kendo practice. AstraZeneca is setting […]
Is Japan’s Drug Pricing Squeeze Finally Loosening? Japan has long been a high-pressure pricing environment for […]
Japan has set ambitious goals to advance its bioeconomy, aiming to integrate biotechnology across various sectors […]
Japan represents one of the world’s most demanding pharmaceutical markets, with rigorous quality standards that go […]
Advanced Therapy Medicinal Products (ATMPs) represent a rapidly evolving field in biotechnology, offering transformative therapeutic solutions […]
The rise of Cell and Gene Therapies (CGT) marks a significant advancement in modern medicine, offering […]
Japan’s IVD market presents a significant opportunity for international companies expanding into Asia. The advanced healthcare […]
Innovation is often misunderstood as merely the introduction of new ideas or products. Even more frequently, […]